VISTAGEN THERAPEUTICS INC (VTGN)
US92840H4002 - Common Stock
| MRQ (2024-9-30) | 2024 (2024-3-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | 2021 (2021-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 84.25M | 119.17M | 16.60M | 68.10M | 103.10M | |||
| Marketable Securities | 13.33M | N/A | N/A | N/A | N/A | |||
| Receivables | N/A | N/A | 300.00K | 300.00K | 0.00 | |||
| Other Current Assets | 2.37M | 1.51M | 600.00K | 2.50M | 900.00K | |||
| Total Current Assets | 99.95M | 120.67M | 17.50M | 71.00M | 104.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | 2.05M | 2.25M | 2.80M | 3.10M | 3.60M | |||
| Other Non-Current Assets | 498.00K | 726.00K | 800.00K | 600.00K | 600.00K | |||
| Total Non-Current Assets | 2.55M | 2.98M | 3.60M | 3.60M | 4.20M | |||
| TOTAL ASSETS | 102.50M | 123.65M | 21.10M | 74.60M | 108.30M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 100.00K | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 4.34M | 2.79M | 1.30M | 1.80M | 1.90M | |||
| Accounts Payable | 715.00K | 1.55M | 2.50M | 2.80M | 800.00K | |||
| Other Current Liabilities | 2.47M | 791.00K | 700.00K | 1.20M | 1.40M | |||
| Total Current Liabilities | 7.52M | 5.12M | 4.60M | 5.80M | 4.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 2.00M | 4.24M | 4.40M | 4.20M | 12.10M | |||
| Total Non-Current Liabilities | 2.00M | 4.24M | 4.40M | 4.10M | 12.10M | |||
| TOTAL LIABILITIES | 9.52M | 9.37M | 9.00M | 9.90M | 16.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -379.91M | -356.21M | -326.90M | -267.60M | -219.80M | |||
| Additional Paid In Capital | 476.80M | 474.44M | 342.90M | 336.10M | 315.60M | |||
| Common Shares | 27.00K | 27.00K | 0.00 | 200.00K | 200.00K | |||
| Treasury Stock | -3.97M | -3.97M | -4.00M | -4.00M | -4.00M | |||
| Other Shareholders' Equity | 22.00K | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 27.06M | 27.03M | 7.30M | 6.90M | 6.00M | |||
| Tangible Book Value per Share | 3.44 | 4.23 | 1.66 | 9.38 | 15.33 | |||
| Total Shareholders' Equity | 92.97M | 114.29M | 12.10M | 64.70M | 92.00M | |||
| TOTAL LIABILITIES AND EQUITY | 102.50M | 123.65M | 21.10M | 74.60M | 108.30M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 13.29 | 23.55 | 3.80 | 12.24 | 24.79 | |||
| Return On Assets (ROA) | -38.60% | -23.75% | -280.81% | -65.29% | -39.08% | |||
| Return On Equity (ROE) | -42.56% | -25.69% | -489.67% | -75.29% | -46.00% | |||
All data in USD , ROIC based on taxRate of 0.21